Skip to main content
Account

Peer review reports

From: Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer

Original Submission
19 Jul 2023 Submitted Original manuscript
12 Aug 2023 Reviewed Reviewer Report - Mark S. Soloway
14 Aug 2023 Reviewed Reviewer Report - Kim Moretti
24 Aug 2023 Author responded Author comments - Giorgio Gandaglia
Resubmission - Version 2
24 Aug 2023 Submitted Manuscript version 2
Publishing
3 Sep 2023 Editorially accepted
30 Sep 2023 Article published 10.1186/s12894-023-01315-5

Learn about peer review

Back to article page

Navigation